{"nct_id":"NCT02557516","title":"Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL","status":"TERMINATED","status_verified_date":"2019-12","start_date":"2015-11-09","start_date_type":"ACTUAL","primary_completion_date":"2018-10-29","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["IPHA"]}